N-Ethyl-nor-pentedrone
| NEP | |
|---|---|
| Molecular structure via molpic based on CDK |
| Rotamer [] | |
|---|---|
| Conformer structure via 3Dmol.js |
| Physical properties [] | |
|---|---|
| Molecular mass | 205.30 g/mol [1] |
| Predicted LogP | 2.9 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C13H19NO [1] |
| IUPAC name | 2-(ethylamino)-1-phenylpentan-1-one [1] |
| SMILES | CCCC(C(=O)C1=CC=CC=C1)NCC [1] |
| InChI | InChI=1S/C13H19NO/c1-3-8-12(14-4-2)13(15)11-9-6-5-7-10-11/h5-7,9-10,12,14H,3-4,8H2,1-2H3 [1] |
| InChIKey | QQAHEGDXEXIQPR-UHFFFAOYSA-N [1] |
| Dosing[] |
|---|
| Insufflated [] | |
|---|---|
| Light | ≤ 26.3 mg(74x - 34.1%) |
| Common | 26.3 - 32 mg(38x - 17.5%) |
| Strong | 32 - 42 mg(55x - 25.3%) |
| Heavy | 42 - 50 mg(30x - 13.8%) |
| Extreme | 50 mg +(20x - 9.2%) |
| Intravenous [] | |
|---|---|
| Light | ≤ 15.7 mg(10x - 37%) |
| Common | 15.7 - 20 mg(10x - 37%) |
| Strong | 20 - 25 mg |
| Heavy | 25 - 30 mg(7x - 25.9%) |
| Extreme | 30 mg + |
| Oral [] | |
|---|---|
| Light | ≤ 23.8 mg(1x - 25%) |
| Common | 23.8 - 30 mg(2x - 50%) |
| Strong | 30 - 35 mg |
| Heavy | 35 - 44 mg |
| Extreme | 44 mg +(1x - 25%) |
| Intrarectal [] | |
|---|---|
| Light | ≤ 38.8 mg(1x - 50%) |
| Common | 38.8 - 47.5 mg |
| Strong | 47.5 - 56.3 mg |
| Heavy | 56.3 - 61.5 mg |
| Extreme | 61.5 mg +(1x - 50%) |
Statistically derived dosages via DBI-IGS We do not take any responsibility for medical complications or loss of life sustained by following these dosages blindly. |
N-Ethyl-nor-pentedrone (also known as Dtxsid201024619, Dtxcid101449652, J3.131.462c, 1-Pentanone, 2-(ethylamino)-1-phenyl-, α-Ethylaminopentiophenone, α-Eapp, N-ethyl-Pentedrone, EAPP, N-ethylpentedrone or N-ethylaminopentiophenone) is a stimulant substance of the cathinone class.
Chemistry
Stereochemistry []
N-Ethyl-nor-pentedrone is a racemic mixture of the enantiomers.
| Stereoisomerism |
|---|
| Stereoisomer enumberation with rdkit |
Subjective effects []
| bonzi / N-Ethyl-nor-pentedrone [] | |
|---|---|
| x86pup / N-Ethyl-nor-pentedrone [] | |
|---|---|
Routes:
| |
| 0xea / N-Ethyl-nor-pentedrone [] | |
|---|---|
Routes:
| |
Experience reports []
There are currently 6 experience reports involving n-ethyl-nor-pentedrone on Erowid:
Legal status []
- Brazil: N-Ethyl-nor-pentedrone is a F2 substance.[3]
- Germany: N-Ethyl-nor-pentedrone is a Neuer-Psychoaktiver-Stoff under the "Neue-psychoaktive-Stoffe-Gesetz (NpSG)".
- United Kingdom: N-Ethyl-nor-pentedrone is a Class B substance.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 205593, 2-(Ethylamino)-1-phenyl-1-pentanone. Accessed May 11, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/205593
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. N-Ethyl-nor-pentedrone. UNII: B483GRH93Q. Global Substance Registration System. Accessed May 11, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/B483GRH93Q
Anvisa. RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. July 24, 2023. Accessed May 11, 2026. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451